The latest research study “Radiodermatitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global radiodermatitis market size reached a value of US$ 464.4 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 579.5 Million by 2027, exhibiting a CAGR of 3.60% during 2022-2027.
Radiodermatitis, also known as radiation dermatitis, refers to a skin condition caused by radiation therapy used to treat cancer. It is generally a side effect that occurs during cancer treatment or after interventional radiology in patients suffering from cancers of the skin, neck, head, breast, lungs, or perineum region where the skin is part of the target field. It can be treated using various products, such as topical antibiotics, oral analgesics, corticosteroids, hydrophilic creams, hydrogel, anti-inflammatory agents, and hydrocolloid, silicone-coated and silver-leaf dressings. Since it helps reduce discomfort, decrease pain, and prevent interruption in ongoing therapy while improving the patient’s overall quality of life, radiodermatitis treatment is gaining immense traction across the globe.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/radiodermatitis-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Radiodermatitis Market Trends and Drivers:
The global radiodermatitis market is primarily driven by the increasing prevalence of cancer and the surging adoption of radiation therapy as a treatment option. Moreover, several favorable initiatives have been taken by numerous governing and non-governing agencies to generate awareness about available radiodermatitis management products and treatments.
In line with this, the increasing public and private investments in ongoing research and development (R&D) projects in the life sciences field are positively influencing the market growth. Besides this, the rising need to counter the adverse side effects of radiation therapy and expanding geriatric population have augmented the product demand.
Other factors, including favorable government policies, improving healthcare infrastructure, easy availability of generic drugs, ongoing clinical trials, and inflating consumer disposable incomes, are also anticipated to drive the market further.
Inquire Before Buying : https://www.imarcgroup.com/request?type=report&id=5638&flag=F
Global Radiodermatitis Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
3M Company, Bausch Health Companies Inc., Bayer AG, BMG PHARMA S.p.A., Charles River Laboratories International Inc., ConvaTec Group plc, Helsinn Healthcare SA, ICON plc, Integra LifeSciences, Mölnlycke Health Care AB and Stratpharma AG.
The report has segmented the market on the basis of region, product and distribution channel.
Breakup by Product:
- Hydrophilic Creams
- Hydrogel and Hydrocolloid Dressings
- No Sting Barrier Film
- Honey Impregnated Gauze
- Silicone Coated Dressings
Breakup by Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=5638&flag=C
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800